Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (SHE:002399)

China flag China · Delayed Price · Currency is CNY
11.35
-0.09 (-0.79%)
At close: Mar 9, 2026
0.89%
Market Cap 15.17B
Revenue (ttm) 5.38B
Net Income (ttm) 420.20M
Shares Out 1.47B
EPS (ttm) 0.29
PE Ratio 39.70
Forward PE 19.40
Dividend 0.25 (2.19%)
Ex-Dividend Date n/a
Volume 4,404,404
Average Volume 4,128,332
Open 11.42
Previous Close 11.44
Day's Range 11.20 - 11.47
52-Week Range 9.72 - 14.34
Beta 0.45
RSI 35.05
Earnings Date Mar 31, 2026

About SHE:002399

Shenzhen Hepalink Pharmaceutical Group Co., Ltd. provides pharmaceutical products in Hong Kong, the United States, Europe, Mainland China, and internationally. It operates in four segments: Finished Dose Pharmaceutical Products, Active Pharmaceutical Ingredients (API), Contract Development and Manufacturing Organization (CDMO), and Others. The company offers finished dose pharmaceutical products, such as prolongin, inhixa, neoparin, and heparin and enoxaparin sodium injections; API products, including heparin and enoxaparin sodium APIs; and pan... [Read more]

Sector Healthcare
Founded 1998
Employees 1,926
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002399
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.